Celadon Pharmaceuticals (CEL)

Sector:

Alternative Investment Instruments

Index:

FTSE AIM All-Share

13.75p
   
  • Change Today:
    -1.75p
  • 52 Week High: 125.00p
  • 52 Week Low: 12.06p
  • Currency: UK Pounds
  • Shares Issued: 68.85m
  • Volume: 332,250
  • Market Cap: £9.47m
  • RiskGrade: 111
  • Beta: 0.11
Sorry, there are no dividends available for this company.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

CEL Market Data

Currency UK Pounds
Share Price 13.75p
Change Today -1.75p
% Change -11.29 %
52 Week High 125.00p
52 Week Low 12.06p
Volume 332,250
Shares Issued 68.85m
Market Cap £9.47m
Beta 0.11
RiskGrade 111

CEL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
68.89% below the sector average68.89% below the sector average68.89% below the sector average68.89% below the sector average68.89% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
86.44% below the sector average86.44% below the sector average86.44% below the sector average86.44% below the sector average86.44% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

CEL Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:06 183 @ 15.00p
16:06 66 @ 15.00p
16:06 25,000 @ 12.15p
15:36 67 @ 15.00p
15:18 3,365 @ 12.15p

CEL Key Personnel

CEO James Short
CFO Jonathan Turner

Top of Page